{"slug":"pt-141-ozempic-face","verification":{"valid":true,"entries":2,"head":"d1bc06263f33c762b3e23fa22d63992595e994b5dd905089ffd7bec812c2dad0"},"energy":{"passes":2,"tokens_in":22968,"tokens_out":3421,"tokens_total":26389,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d1bc06263f33c762b3e23fa22d63992595e994b5dd905089ffd7bec812c2dad0"},"provenance":[{"ts":"2026-06-30T01:12:05.511Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Ozempic Face\nSlug: pt-141-ozempic-face\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"GLP-1 facial collagen loss\",\"condition_key\":\"ozempic-face\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have GLP-1 facial collagen loss\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **GLP-1 facial collagen loss** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **GLP-1 facial collagen loss** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have GLP-1 facial collagen loss\",\"Why PT-141 might ","response":"{\n  \"slug\": \"pt-141-ozempic-face\",\n  \"title\": \"PT-141 for Ozempic Face: Evidence Review on CNS Pathways and Tissue Considerations\",\n  \"body\": \"## What's breaking down if you have GLP-1 facial collagen loss\\n\\nRapid weight loss from GLP-1 agonists like semaglutide often reduces facial fat volume first. Skin then loses support and elasticity. Collagen production may slow while breakdown continues. The result is a hollow or sagging appearance commonly called Ozempic face. This is a degeneration process where tissue repair lags behind the mechanical and metabolic changes of weight loss.\\n\\nIf facial volume drops quickly, the dermis experiences increased mechanical stress. Repair pathways involving fibroblasts and extracellular matrix may not keep pace. No approved compound directly reverses this; discussions focus on whether certain agents influence related biological layers.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **GLP-1 facial collagen loss** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts as a melanocortin receptor agonist primarily in the central nervous system. This pathway links to arousal and desire in human studies. Melanocortin receptors also appear in skin and pigmentation processes. If CNS signaling influences peripheral tissue maintenance in your case, the compound enters the conversation through that route rather than direct anti-inflammatory or growth-factor effects.\\n\\nThe logic stays specific: the compound engages receptors tied to arousal circuits. Any tissue-level discussion follows from receptor distribution, not from symptom suppression alone.\\n\\n## How these fit together\\n\\nSingle-compound focus — PT-141 targets the sexual / CNS arousal layer. Siblings in broader stacks would address other degeneration layers if present in a full condition profile.\\n\\n## What th","tokens_in":22968,"tokens_out":3421,"cost":0,"prev":"genesis","hash":"e213493508f0835bbf50efb3f99bd70b71c07767117113be2665b0c602871da7"},{"ts":"2026-07-17T02:41:08.782Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-ozempic-face","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e213493508f0835bbf50efb3f99bd70b71c07767117113be2665b0c602871da7","hash":"d1bc06263f33c762b3e23fa22d63992595e994b5dd905089ffd7bec812c2dad0"}]}